DD202714A5 - Verfahren zur herstellung 3-substituierter indolylacrylsaeurederivate - Google Patents

Verfahren zur herstellung 3-substituierter indolylacrylsaeurederivate Download PDF

Info

Publication number
DD202714A5
DD202714A5 DD82241446A DD24144682A DD202714A5 DD 202714 A5 DD202714 A5 DD 202714A5 DD 82241446 A DD82241446 A DD 82241446A DD 24144682 A DD24144682 A DD 24144682A DD 202714 A5 DD202714 A5 DD 202714A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
deep
compounds
alkyl
Prior art date
Application number
DD82241446A
Other languages
German (de)
English (en)
Inventor
Peter E Cross
Roger P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD202714A5 publication Critical patent/DD202714A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD82241446A 1981-07-07 1982-07-06 Verfahren zur herstellung 3-substituierter indolylacrylsaeurederivate DD202714A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8120878 1981-07-07
GB8213864 1982-05-13

Publications (1)

Publication Number Publication Date
DD202714A5 true DD202714A5 (de) 1983-09-28

Family

ID=26280039

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82241446A DD202714A5 (de) 1981-07-07 1982-07-06 Verfahren zur herstellung 3-substituierter indolylacrylsaeurederivate

Country Status (17)

Country Link
US (1) US4451472A (da)
EP (1) EP0069513B1 (da)
AR (1) AR230056A1 (da)
AU (1) AU532640B2 (da)
CS (1) CS229934B2 (da)
DD (1) DD202714A5 (da)
DE (1) DE3275545D1 (da)
DK (1) DK297382A (da)
ES (1) ES513765A0 (da)
FI (1) FI822386L (da)
GB (1) GB2101992A (da)
GR (1) GR76214B (da)
IL (1) IL66223A0 (da)
NO (1) NO822360L (da)
PL (1) PL240814A1 (da)
PT (1) PT75191B (da)
YU (1) YU145482A (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
EP0427860A1 (en) * 1989-03-31 1991-05-22 Kyoto Pharmaceutical Industries, Ltd. New imidazole derivatives, production thereof, and uses thereof as medicines
JPH03258779A (ja) * 1990-03-06 1991-11-19 Mitsui Toatsu Chem Inc イミダゾール誘導体及び該イミダゾール誘導体を有効成分とする抗痙攣剤
US5538973A (en) * 1992-03-27 1996-07-23 Kyoto Pharmaceutical Industries, Ltd. Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
GB9310635D0 (en) * 1993-05-21 1993-07-07 Glaxo Group Ltd Chemical compounds
GB9319100D0 (en) * 1993-09-15 1993-11-03 Pfizer Ltd 3-(3-pyridinyl)h-indoles
KR102022716B1 (ko) 2011-07-29 2019-09-18 카리오팜 쎄라퓨틱스, 인코포레이티드 하이드라지드 함유 핵 수송 조절인자 및 이의 용도
SI3404027T1 (sl) 2012-05-09 2020-08-31 Biogen Ma Inc. Modulatorji jedrnega transporta in njihova uporaba
WO2014144772A1 (en) 2013-03-15 2014-09-18 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
DK3492455T3 (da) 2013-06-21 2023-08-14 Karyopharm Therapeutics Inc 1,2,4-triazoler som nukleare transportmodulatorer og anvendelse til behandling af specifikke former for cancer
SG10201808624VA (en) 2014-08-15 2018-11-29 Karyopharm Therapeutics Inc Polymorphs of selinexor
WO2017117535A1 (en) 2015-12-31 2017-07-06 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
EP3397633A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
US11602530B2 (en) 2016-11-28 2023-03-14 Biogen Ma Inc. CRM1 inhibitors for treating epilepsy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3462440A (en) * 1965-12-03 1969-08-19 American Home Prod 1,4-bis(2-indol-3-ylethyl)piperidines
FR2272081A1 (en) * 1974-05-22 1975-12-19 Labaz Anti-inflammatory indolylpyridylketones prepn. - from 2-alkyl (or aryl) indole and pyridine carboxylic acid chlorides
DE2960547D1 (en) * 1978-02-24 1981-11-05 Pfizer Ltd 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them
IT1162310B (it) * 1978-05-02 1987-03-25 Ono Pharmaceutical Co Derivati di imidazolo e procedimento per produrli
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
GB2045244B (en) * 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4363912A (en) * 1980-12-15 1982-12-14 Pfizer Inc. Indole thromboxane synthetase inhibitors

Also Published As

Publication number Publication date
AR230056A1 (es) 1984-02-29
PL240814A1 (en) 1983-10-10
NO822360L (no) 1983-01-10
GB2101992A (en) 1983-01-26
EP0069513A2 (en) 1983-01-12
CS229934B2 (en) 1984-07-16
ES8305355A1 (es) 1983-04-01
YU145482A (en) 1985-03-20
ES513765A0 (es) 1983-04-01
DK297382A (da) 1983-01-08
FI822386A0 (fi) 1982-07-05
DE3275545D1 (en) 1987-04-09
FI822386L (fi) 1983-01-08
EP0069513B1 (en) 1987-03-04
AU532640B2 (en) 1983-10-06
AU8563882A (en) 1983-02-03
EP0069513A3 (en) 1984-03-21
PT75191A (en) 1982-08-01
IL66223A0 (en) 1982-11-30
US4451472A (en) 1984-05-29
GR76214B (da) 1984-08-04
PT75191B (en) 1985-10-04

Similar Documents

Publication Publication Date Title
DE3008632C2 (da)
DD215546A5 (de) Verfahren zur herstellung bicyclischer thromboxansynthetase-inhibitoren
CH646154A5 (de) Imidazol-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel.
CH644597A5 (de) Imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
EP1198453B9 (de) N-(indolcarbonyl-)piperazinderivate als 5-ht2a-rezeptor liganden
DD202290A5 (de) Verfahren zur herstellung von indolderivaten
DD202714A5 (de) Verfahren zur herstellung 3-substituierter indolylacrylsaeurederivate
DD264919A5 (de) Verfahren zur herstellung von 5-hydroxy-3-aminochromanen
CH646426A5 (en) Process for the preparation of hydantoin derivatives
EP0007399B1 (de) Indolalkylamine, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
US4230714A (en) Imidazole therapeutic agents
EP0095640A1 (de) Alkylenverbrückte Guanidinothiazolderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DD229402A5 (de) Verfahren zur herstellung von piperidinion-derivaten, die als myocard-schutz eine antiarrhytmische aktivitaet ausweisen
DE3326164A1 (de) Neue p-oxibenzoesaeure-derivate, sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP1228041A2 (de) Indolderivate und deren verwendung als 5ht2a liganden
CH642348A5 (de) Alkylthiophenoxyalkylamine.
CH622516A5 (en) Process for the preparation of substituted indoles, and their use
EP0194579A2 (de) Neue 3-Pyridylmethylnaphthylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0401798B1 (de) Substituierte Aminoalkylbenzolderivate
DD209194A5 (de) Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DE4204686A1 (de) Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
DE2522218B2 (de) Zusammensetzung für die Human- oder Veterinärmedizin, Methylaminderivate und Verfahren zu deren Herstellung
EP0388739A1 (de) Tetrahydronaphtalinderivate
DE2656227C2 (de) Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
AT295516B (de) Verfahren zur Herstellung neuer cyclischer Amidine und ihrer Salze